Allogene Therapeutics, Inc.
ALLO
$1.77
-$0.09-4.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.78% | -4.70% | -14.45% | -13.50% | -38.57% |
| Total Receivables | 29.41% | -43.48% | -21.05% | -25.00% | -15.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.68% | -44.69% | -32.97% | -36.08% | -25.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.29% | -6.27% | -15.04% | -14.35% | -38.17% |
|
|
|||||
| Total Current Assets | 20.29% | -6.27% | -15.04% | -14.35% | -38.17% |
| Net Property, Plant & Equipment | -13.00% | -14.34% | -14.12% | -13.65% | -19.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -62.81% | -59.14% | 11.97% | -0.81% | -1.46% |
| Total Assets | 16.89% | -22.05% | -24.20% | -25.35% | -27.25% |
|
|
|||||
| Total Accounts Payable | 22.94% | -2.47% | -20.84% | -32.82% | -62.50% |
| Total Accrued Expenses | -10.28% | -13.58% | -18.14% | 2.29% | 11.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.60% | 10.31% | 9.31% | 8.38% | 7.41% |
| Total Finance Division Other Current Liabilities | -- | -- | 123.60% | -- | -- |
| Total Other Current Liabilities | -- | -- | 123.60% | -- | -- |
| Total Current Liabilities | 0.16% | -5.64% | -8.47% | -2.27% | -15.09% |
|
|
|||||
| Total Current Liabilities | 0.16% | -5.64% | -8.47% | -2.27% | -15.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.22% | -10.65% | -9.85% | -9.40% | -8.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.70% | 42.97% | 103.63% | 101.87% | 100.19% |
| Total Liabilities | -9.61% | -4.49% | -2.50% | -0.74% | -4.41% |
|
|
|||||
| Common Stock & APIC | 11.32% | 2.98% | 2.72% | 2.86% | 2.97% |
| Retained Earnings | -8.57% | -9.24% | -10.49% | -12.05% | -13.99% |
| Treasury Stock & Other | -1,051.11% | -525.58% | 402.25% | 49.68% | 94.23% |
| Total Common Equity | 26.59% | -27.64% | -30.71% | -32.00% | -33.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.59% | -27.64% | -30.71% | -32.00% | -33.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.59% | -27.64% | -30.71% | -32.00% | -33.10% |
|
|
|||||